{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
INN:cofetuzumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03516981: Phase 2 Interventional Active, not recruiting Advanced Non-Small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mupadolimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04620811: Phase 3 Interventional Completed Eosinophilic Gastritis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02290951: Phase 1 Interventional Active, not recruiting Non-Hodgkin Lymphoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03902184: Phase 2 Interventional Active, not recruiting Lymphoma, T-Cell
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03858634: Phase 2 Interventional Completed Chronic Idiopathic Urticaria
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:galegenimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04126200: Phase 2 Interventional Active, not recruiting Multiple Myeloma
(2019)
Source URL:
Class:
PROTEIN
